Dendritic cells dictate the responsiveness to PD-L1 blockade in cancer

被引：0

作者：

Mayoux, M. ^{[1
]}

Roller, A. ^{[2
]}

Pulko, V ^{[1
]}

Chen, S. ^{[1
]}

Fransen, M. ^{[3
]}

Kowanetz, M. ^{[4
]}

Rommel, K. ^{[1
]}

Matos, I ^{[1
]}

Colombetti, S. ^{[1
]}

Belousov, A. ^{[5
]}

Karanikas, V ^{[1
]}

Hegde, P. ^{[4
]}

Chen, D. ^{[4
]}

Mellman, I ^{[4
]}

Umana, P. ^{[1
]}

Perro, M. ^{[1
]}

Ossendorp, F. ^{[3
]}

Klein, C. ^{[1
]}

Xu, W. ^{[1
]}

机构：

[1] Roche Innovat Ctr Zurich, Schlieren, Switzerland

[2] Roche Innovat Ctr Basel, Basel, Switzerland

[3] Leiden Univ, Med Ctr, Leiden, Netherlands

[4] Genentech Inc, San Francisco, CA USA

[5] Roche Innovat Ctr Munich, Penzberg, Germany

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2018年 / 48卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

T-40

引用

页码：22 / 23

页数：2

共 50 条

[21] PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Hamanishi, Junzo
Mandai, Masaki
Matsumura, Noriomi
Abiko, Kaoru
Baba, Tsukasa
Konishi, Ikuo
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (03) : 462 - 473
[22] PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi
Masaki Mandai
Noriomi Matsumura
Kaoru Abiko
Tsukasa Baba
Ikuo Konishi
International Journal of Clinical Oncology, 2016, 21 : 462 - 473
[23] Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
Huang, Kevin Chih-Yang
Chiang, Shu-Fen
Chen, William Tzu-Liang
Chen, Tsung-Wei
Hu, Ching-Han
Yang, Pei-Chen
Ke, Tao-Wei
Chao, K. S. Clifford
CANCERS, 2020, 12 (02)
[24] A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma
Zhang, Min
Bzura, Aleksandra
Baitei, Essa Y.
Zhou, Zisen
Spicer, Jake B.
Poile, Charlotte
Rogel, Jan
Branson, Amy
King, Amy
Barber, Shaun
Kamata, Tamihiro
Dzialo, Joanna
Harber, James
Greystoke, Alastair
Nusrat, Nada
Faulkner, Daniel
Sun, Qianqian
Nolan, Luke
Hahne, Jens C.
Scotland, Molly
Walter, Harriet
Darlison, Liz
Morgan, Bruno
Bajaj, Amrita
Brookes, Cassandra
Hollox, Edward J.
Lubawska, Dominika
Jama, Maymun
Griffiths, Gareth
Nakas, Apostolos
Kutywayo, Kudzayi
Luo, Jin-Li
Klampatsa, Astero
Cooper, Andrea
Halder, Koirobi
Wells-Jordan, Peter
Zhou, Huiyu
Dudbridge, Frank
Thomas, Anne
Richards, Catherine Jane
Pritchard, Catrin
Yang, Hongji
Barer, Michael
Fennell, Dean A.
NATURE COMMUNICATIONS, 2024, 15 (01)
[25] Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies
Tan, Zhaoli
Yue, Chunyan
Ji, Shoujian
Zhao, Chuanhua
Jia, Ru
Zhang, Yun
Liu, Rongrui
Li, Da
Yu, Qian
Li, Ping
Hu, Zhiyuan
Yang, Yanlian
Xu, Jianming
ONCOLOGIST, 2021, : e2227 - e2238
[26] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
Lin, Heng
Wei, Shuang
Vatan, Linda
Kryczek, Ilona
Zou, Weiping
JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
[27] PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
Qi Peng
Xiangyan Qiu
Zihan Zhang
Silin Zhang
Yuanyuan Zhang
Yong Liang
Jingya Guo
Hua Peng
Mingyi Chen
Yang-Xin Fu
Haidong Tang
Nature Communications, 11
[28] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
Bai, Jie
Gao, Zhitao
Li, Xiang
Dong, Liang
Han, Weidong
Nie, Jing
ONCOTARGET, 2017, 8 (66) : 110693 - 110707
[29] PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
Peng, Qi
Qiu, Xiangyan
Zhang, Zihan
Zhang, Silin
Zhang, Yuanyuan
Liang, Yong
Guo, Jingya
Peng, Hua
Chen, Mingyi
Fu, Yang-Xin
Tang, Haidong
NATURE COMMUNICATIONS, 2020, 11 (01)
[30] Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
Zhang, Min
Liu, Kehai
Wang, Mingfu
RSC ADVANCES, 2019, 9 (58) : 33903 - 33911

← 1 2 3 4 5 →